statistiche ricercatore

Continente	#
NA - Nord America	674
EU - Europa	585
AS - Asia	510
SA - Sud America	61
AF - Africa	9
Continente sconosciuto - Info sul continente non disponibili	1
OC - Oceania	1
Totale	1.841

Nazione	#
US - Stati Uniti d'America	662
RU - Federazione Russa	220
CN - Cina	207
SG - Singapore	167
GB - Regno Unito	159
IT - Italia	64
BR - Brasile	53
VN - Vietnam	52
HK - Hong Kong	35
FR - Francia	32
SE - Svezia	27
DE - Germania	20
FI - Finlandia	20
KR - Corea	17
IE - Irlanda	15
BE - Belgio	11
IN - India	9
ZA - Sudafrica	7
CA - Canada	6
BD - Bangladesh	4
ES - Italia	4
JP - Giappone	3
PK - Pakistan	3
PL - Polonia	3
TR - Turchia	3
UY - Uruguay	3
EC - Ecuador	2
GT - Guatemala	2
ID - Indonesia	2
LV - Lettonia	2
MX - Messico	2
NL - Olanda	2
UA - Ucraina	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AR - Argentina	1
AU - Australia	1
BG - Bulgaria	1
CL - Cile	1
CR - Costa Rica	1
GL - Groenlandia	1
IL - Israele	1
IQ - Iraq	1
NG - Nigeria	1
NP - Nepal	1
PT - Portogallo	1
RS - Serbia	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
TW - Taiwan	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.841

Nome	#
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase	298
Allele-specific Characterization of Alanine: Glyoxylate Aminotransferase Variants Associated with Primary Hyperoxaluria	293
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine	220
THE DEFICIT OF ALANINE:GLYOXYLATE AMINOTRANSFERASE LEADS TO PRIMARY HYPEROXALURIA TYPE I: A BIOCHEMICAL STUDY TO UNDERSTAND THE ROLE OF INTERALLELIC COMPLEMENTATION IN COMPOUND HETEROZYGOUS PATIENTS AND TO PROJECT THE DEVELOPMENT OF AN ENZYME ADMINISTRATION THERAPY.	212
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine	204
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I	164
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation.	162
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I	152
Rapid profiling of disease alleles using a tunable reporter of protein misfolding	148
Totale	1.853

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	12	0	0	0	0	0	0	0	0	0	1	9	2
2021/2022	125	11	48	7	2	6	5	5	6	5	3	7	20
2022/2023	188	13	28	17	31	18	32	3	12	22	0	7	5
2023/2024	80	6	5	4	4	11	13	2	14	0	6	13	2
2024/2025	234	13	21	4	40	9	12	16	10	40	21	21	27
2025/2026	731	54	33	91	105	190	69	71	44	29	45	0	0
Totale													1.853

CATALOGO DEI PRODOTTI DELLA RICERCA